GNH USA

Europe — EMA

Lamivudin Aurobindo

GNH USA supplies Lamivudin Aurobindo (Lamivudine), a reverse transcriptase inhibitor for HIV infection and chronic hepatitis B. Request a quote today.

Lamivudine

Request sourcing

1
Pack/s

What is Lamivudine?

Lamivudine, the active ingredient in Lamivudin Aurobindo, is a nucleoside reverse transcriptase inhibitor (NRTI) presented as an oral tablet for oral use. It treats HIV infection and chronic hepatitis B in adult patients and is manufactured under EU GMP standards for clinical use.

GNH USA supplies Lamivudin Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Lamivudine used for?

Lamivudin Aurobindo is used in antiretroviral therapy and antiviral management of hepatitis B. - HIV infection: reduces viral load and slows disease progression. - HIV-2 infection: contributes to viral suppression in patients infected with HIV‑2. - Chronic hepatitis B infection: suppresses HBV replication and improves liver function.

What are the side effects of Lamivudine?

Lamivudin Aurobindo may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Diarrhea: loose stools, usually self‑limiting. - Fatigue: general tiredness.

Serious or Rare Side Effects: - Lactic acidosis: severe metabolic disturbance requiring urgent care. - Severe hepatotoxicity: liver injury with jaundice or elevated enzymes. - Pancreatitis: inflammation of the pancreas presenting with abdominal pain.

What precautions apply to Lamivudine?

Before initiating therapy, consider the following precautions. - Monitor liver function: assess enzymes regularly due to potential hepatotoxicity. - Assess renal function: dose adjustment may be needed in renal impairment. - Screen for hepatitis B co‑infection: avoid abrupt discontinuation. - Counsel on adherence: maintain consistent dosing to prevent resistance. - Avoid in patients with known hypersensitivity to lamivudine. - Store at below 25°C: keep in the original pack, protect from moisture.

What does Lamivudine interact with?

Lamivudin Aurobindo can interact with several medicines.

Major Interactions (Avoid): - Didanosine: increased risk of pancreatitis. - Stavudine: heightened mitochondrial toxicity. - Tenofovir: potential additive renal toxicity.

Moderate Interactions (Monitor Closely): - Alcohol: may exacerbate liver injury. - Antacids containing aluminum or magnesium: may reduce lamivudine absorption.

Frequently asked questions

What conditions is Lamivudin Aurobindo used to treat?+
Lamivudin Aurobindo is prescribed for the management of HIV infection, including HIV‑1 and HIV‑2, and for chronic hepatitis B infection. In both diseases it helps to suppress viral replication and improve clinical outcomes when used as part of an approved treatment regimen.
How does lamivudine work in the body?+
Lamivudine is taken up by cells and converted to its active triphosphate form. This active molecule mimics the natural nucleoside deoxycytidine and is incorporated into viral DNA by reverse transcriptase, causing premature chain termination and preventing the virus from copying its genetic material.
What is the usual dose of Lamivudin Aurobindo?+
The specific dose of Lamivudin Aurobindo is determined by the prescribing clinician based on the patient’s condition, weight, renal function and other individual factors. Only a qualified health professional should set the dosing schedule and any adjustments.
Is Lamivudin Aurobindo safe during pregnancy or breastfeeding?+
Safety data for lamivudine in pregnancy are limited, and the pregnancy category is listed as unknown. The drug should only be used if the potential benefit justifies any possible risk to the fetus. Breastfeeding decisions should be made in consultation with a health professional.
How do I order Lamivudin Aurobindo from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does lamivudine compare with other antiretroviral drugs?+
Lamivudine belongs to the nucleoside reverse transcriptase inhibitor class and is often combined with other agents for synergistic effect. Compared with older NRTIs, it has a more favorable safety profile and a lower risk of mitochondrial toxicity, but resistance can develop if used without adequate combination therapy.
What are the recommended storage conditions for Lamivudin Aurobindo?+
Lamivudin Aurobindo should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keeping the product in a dry, controlled environment helps maintain its potency throughout its shelf life.
How is Lamivudin Aurobindo administered?+
The medication is taken orally, usually as a tablet, with or without food as directed by the prescriber. Swallow the tablet whole with water and follow the dosing schedule provided by the healthcare professional to ensure consistent drug levels.
What are the most serious risks associated with lamivudine therapy?+
Serious adverse events, although rare, include lactic acidosis, severe hepatotoxicity and pancreatitis. Patients should be monitored for signs such as unexplained fatigue, abdominal pain, jaundice or rapid weight loss, and medical attention should be sought immediately if these occur.
Who should not take Lamivudin Aurobindo?+
Individuals with a known hypersensitivity to lamivudine or any of the tablet’s excipients should avoid the product. Caution is also advised for patients with severe hepatic impairment, advanced renal disease, or those taking contraindicated medications listed under major drug interactions.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Lamivudine
Route
Oral Use
Manufacturer
Puren Pharma Gmbh & Co. Kg
Origin
EU

Related products